PDF icon PDF herunterladen
Semin Respir Crit Care Med 2024; 45(03): 386-396
DOI: 10.1055/s-0044-1782653
Review Article

Systemic Lupus Erythematosus-related Lung Disease

Elisabeth Bendstrup
1   Center for Rare Lung Disease, Department of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus, Denmark
2   Department of Clinical Medicine, Aarhus University, Aarhus, Denmark
,
Evelyn Lynn
3   Department of Respiratory Medicine, St. Vincent's University Hospital, Dublin, Ireland
4   School of Medicine, University College Dublin, Dublin, Ireland
,
Anne Troldborg
2   Department of Clinical Medicine, Aarhus University, Aarhus, Denmark
5   Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark
6   Biomedicine, Aarhus University, Aarhus, Denmark
› Institutsangaben
› Weitere Informationen
   Lizenzen und Reprints
Preview

Abstract

Systemic Lupus Erythematosus (SLE) is a multifaceted, multisystem autoimmune disorder with diverse clinical expressions. While prevalence reports vary widely, pulmonary involvement accounts for significant morbidity and mortality in SLE. This comprehensive review explores the spectrum of pulmonary disease in SLE, including upper airway manifestations (e.g., laryngeal affection), lower airway conditions (e.g., bronchitis, bronchiolitis, bronchiectasis), parenchymal diseases (e.g., interstitial lung disease, acute lupus pneumonitis, diffuse alveolar hemorrhage), pleural diseases (e.g., serositis, shrinking lung syndrome), and vascular diseases (e.g., pulmonary arterial hypertension, pulmonary embolism, acute reversible hypoxemia syndrome). We discuss diagnostic modalities, treatment strategies, and prognosis for each pulmonary manifestation. With diagnostics remaining a challenge and with the absence of standardized treatment guidelines, we emphasize the need for evidence-based guidelines to optimize patient care and improve outcomes in this complex disease.

Keywords

systemic lupus erythematosus - acute lupus pneumonitis - alveolar hemorrhage - pleural effusion - serositis - shrinking lung syndrome - interstitial lung disease - pulmonary hypertension - pulmonary embolism


Publikationsverlauf

Artikel online veröffentlicht:
28. März 2024

© 2024. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA